Aug. 6, 2014, 5:41 PM
Mar. 7, 2014, 5:37 PM
Aug. 5, 2013, 12:22 PM
- Enzo Biochem (ENZ +8.6%) jumps after a Federal Court Judge upholds the jury verdict issued in November, 2012, which awarded the drug developer $48.6M in damages as a result of patent infringement by Applera Corporation, which is now Life Technologies (LIFE -0.1%).
- The court ruled initially that LIFE infringed on ENZ's patent covering pioneering technologies relating to compounds used in DNA sequencing systems to read genetic code.
- The Judge also denied LIFE's request for a finding that Enzo's infringement claims are barred by laches and/or equitable estoppel and its motion for a new trial, as well as ENZ's request for reconsideration seeking additional damages.
- The ruling opens the way for ENZ to recover prejudgment interest on the damages award, which should exceed $25M in addition to the judgment.
Nov. 5, 2012, 12:45 PM
Dec. 13, 2011, 2:03 PM
ENZ vs. ETF Alternatives
Other News & PR